Infliximab population pharmacokinetic modelling in patients with Inflammatory Bowel Disease (IBD): Patient factors influencing infliximab pharmacokinetics

被引：0
|
作者：
Guardiola, J. [1 ]
Rodriguez-Alonso, L. [1 ]
Santacana, E. [2 ]
Padulles, N. [2 ]
Colom, H. [3 ]
Padulles, A. [2 ]
Arajol, C. [1 ]
Ruiz-Cerulla, A. [1 ]
Cobo, S. [2 ]
Bas, J. [4 ]
Climent, J. [4 ]
Morandeira, F. [4 ]
Rodriguez-Moranta, F. [1 ]
机构：
[1] Hosp Univ Bellvitge, Gastroenterol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Bellvitge, Pharm, Lhospitalet De Llobregat, Spain
[3] Univ Barcelona, Sch Pharm, Pharmacokinet, Barcelona, Spain
[4] Hosp Univ Bellvitge, Immunol, Lhospitalet De Llobregat, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P453
引用
收藏
页码：S306 / S307
页数：2
相关论文
共 50 条
  • [1] Infliximab pharmacokinetics in inflammatory Bowel disease patients
    Ternant, David
    Aubourg, Alexandre
    Magdelaine-Beuzelin, Charlotte
    Degenne, Danielle
    Watier, Herve
    Picon, Laurence
    Paintaud, Gilles
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 523 - 529
  • [2] Population Pharmacokinetic Evaluation of Infliximab Reveals Patient Factors That Increase Infliximab Clearance and Shorten Half-Life in Inflammatory Bowel Disease Patients
    Dotan, Iris
    Ron, Yulia
    Yanai, Henit
    Becker, Stuart A.
    Fishman, Sigal
    Yahav, Lior
    Ben Yehoyada, Merav
    Mould, Diane R.
    GASTROENTEROLOGY, 2013, 144 (05) : S774 - S774
  • [3] Pulmonary Histoplasmosis in a Patient With Inflammatory Bowel Disease (IBD) on Infliximab
    Verdone, J. E.
    Pickering, E.
    Sachdeva, A.
    Nasim, F.
    Holden, V. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease
    Santacana, Eugenia
    Rodriguez-Alonso, Lorena
    Padulles, Ariadna
    Guardiola, Jordi
    Rodriguez-Moranta, Francisco
    Serra, Katja
    Bas, Jordi
    Morandeira, Francisco
    Colom, Helena
    Padulles, Nuria
    THERAPEUTIC DRUG MONITORING, 2018, 40 (01) : 120 - 129
  • [5] Infliximab population pharmacokinetic modelling in patients with Inflammatory Bowel Disease: estimation of individual pharmacokinetic parameters and trough levels prediction
    Guardiola, J.
    Rodriguez-Alonso, L.
    Santacana, E.
    Padulles, N.
    Colom, H.
    Padulles, A.
    Ruiz-Cerulla, A.
    Arajol, C.
    Cobo, S.
    Bas, J.
    Climent, J.
    Morandeira, F.
    Rodriguez-Moranta, F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S320 - S321
  • [6] Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
    Guardiola, J.
    Rodriguez Alonso, L.
    Padulles, N.
    Santacana, E.
    Serra, K.
    Padulles, A.
    Ruiz-Cerulla, A.
    Gilabert, P.
    Arajol, C.
    Ibanez-Sanz, G.
    Camps, B.
    Colom, H.
    Bas, J.
    Morandeira, F.
    Sanchez, E.
    Orobitg, J.
    Rodriguez Moranta, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S441 - S441
  • [7] The effect of age on infliximab pharmacokinetics in patients with inflammatory bowel disease
    Kantasiripitak, W.
    Verstockt, B.
    Lobaton, T.
    Thomas, D.
    Gils, A.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S462 - S463
  • [8] Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients
    Gil Candel, Mayte
    Gascon Canovas, Juan Jose
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Rentero Redondo, Lorena
    Urbieta Sanz, Elena
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (08) : 590 - 597
  • [9] Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease
    Wang, Ka Yu
    Heikal, Omnia Salah
    van Rheenen, Patrick F.
    Touw, Daan J.
    Bourgonje, Arno R.
    Mian, Paola
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [10] Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease: A Population Pharmacokinetic Study
    Dotan, Iris
    Ron, Yulia
    Yanai, Henit
    Becker, Stuart
    Fishman, Sigal
    Yahav, Lior
    Ben Yehoyada, Merav
    Mould, Diane R.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (12) : 2247 - 2259
12345